Page 56 - SAMRC Strategic Plan

Programme 2 Technical Indicator Description continued

ASSUMPTIONS The evidence presented to the auditors is reliable, relevant and valid
REPORTING CYCLE Quarterly
DESIRED PERFORMANCE To achieve set target for the reporting period

INDICATOR RESPONSIBILITY Vice President-Extramural Research and Internal Portfolio

INDICATOR TITLE 2.3.1. Number of research grants funded by the SAMRC

Total number of research grants funded by the SAMRC. This
DEFINITION includes new and ongoing grants that received funding during the
reporting period
SOURCE OF DATA GIPD/SHIP/RCD and other relevant internal departments
Count the number of research grants funded by the SAMRC during
METHOD OF CALCULATION/ASSESSMENT
the reporting period
ASSUMPTIONS The evidence presented to the auditors is reliable, relevant and valid
REPORTING CYCLE Annually
DESIRED PERFORMANCE To achieve set target for the reporting period
INDICATOR RESPONSIBILITY Executive Director: Grants Innovation and Product Development

19. Programme 3 Technical Indicator Description

3.1.1. Number of innovation and technology projects funded by the
INDICATOR TITLE SAMRC aimed at developing, testing and/or implementing
new or improved health solutions
Total number of innovation and technology projects funded by the
SAMRC that are aimed at developing, testing and/or implementing
new or improved health solutions, such as, but not limited to, new
diagnostics, vaccines, drugs, e-health interventions, medical devices
DEFINITION and treatment regimens. This includes new and ongoing innovation
and technology projects that received funding during the reporting
period and those that did not receive a funding disbursement during
the reporting period but continued to be executed using funding
previously disbursed by the SAMRC for that purpose
SOURCE OF DATA Grants Innovation and Product Development
Count the number of innovation and technology projects funded by
METHOD OF CALCULATION/ASSESSMENT
the SAMRC during the reporting period
ASSUMPTIONS The evidence presented to the auditors is reliable, relevant and valid
REPORTING CYCLE Annual
DESIRED PERFORMANCE To achieve set target for the reporting period
INDICATOR RESPONSIBILITY Executive Director: Grants Innovation and Product Development

SAMRC STRATEGIC PLAN 2025/26 – 2029/30 55